US Patent Issued to Wuxi Biocity Biopharmaceutics on May 6 for "Crystal form of Wee1 inhibitor compound and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., June 10 -- United States Patent no. 12,291,536, issued on May 6, was assigned to Wuxi Biocity Biopharmaceutics Co. Ltd. (Jiangsu, China).

"Crystal form of Wee1 inhibitor compound and use thereof" was invented by Wenyuan Qian (Shanghai), Chundao Yang (Shanghai), Zhengwei Li (Shanghai), Jie Li (Shanghai), Jian Li (Shanghai) and Shuhui Chen (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is a crystal form of a compound of formula (I) and the use of the crystal form in the preparation of a drug for treating Wee1-related diseases."

The patent was filed on April 30, 2020, under Application No. 17/607,447.

*For further information, including images, charts and tables, please vi...